Cargando…
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a recent advancement in the treatment of cystic fibrosis and were initially approved for their beneficial effect on lung function. There have also been few reports of their positive role in glycemic contro...
Autores principales: | Mehfooz, Ayesha, Zeb, Muhammad, Morey-Vargas, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552780/ http://dx.doi.org/10.1210/js.2019-SUN-LB026 |
Ejemplares similares
-
MON-LB026 Critical Illness Associated Fatal Hypoglycemia in a Non-Diabetic Male
por: Toor, Amit, et al.
Publicado: (2019) -
MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020) -
SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019) -
SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019) -
SUN-LB028 Diabetic Truncal Radiculopathy: An Underrecognized Cause of Thoracic and Abdominal Pain
por: Panday, Deepika, et al.
Publicado: (2019)